CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

BACKGROUND: Chemokine CXC ligand 13 (CXCL13) has been implicated in perivascular inflammation and pulmonary vascular remodeling in patients with idiopathic pulmonary artery hypertension (IPAH). We wondered whether CXCL13 may also play a role in chronic thromboembolic pulmonary hypertension (CTEPH) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Karen M., Olle, Sandra, Fuge, Jan, Welte, Tobias, Hoeper, Marius M., Lerch, Christian, Maegel, Lavinia, Haller, Hermann, Jonigk, Danny, Schiffer, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770535/
https://www.ncbi.nlm.nih.gov/pubmed/26927848
http://dx.doi.org/10.1186/s12931-016-0336-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770535/
https://www.ncbi.nlm.nih.gov/pubmed/26927848
http://dx.doi.org/10.1186/s12931-016-0336-5

Ejemplares similares